Hjem › Brystkreft › Louisiana › New Orleans
Kliniske studier for Brystkreft i New Orleans, LA
11 studier for Brystkreft søker deltakere på steder i og rundt New Orleans (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University Medical Center New Orleans, New Orleans
- Touro Infirmary, New Orleans
- West Jefferson Medical Center, Marrero · 4 mi unna
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- Ochsner Clinic Foundation ( Site 0021), New Orleans
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- University Medical Center-New Orleans, New Orleans
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
RekruttererFase 1
- Ochsner Medical Center (OMC), New Orleans
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruttererFase 3
- Care Access-Marrero, Marrero · 4 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Louisiana State University Health Science Center, New Orleans
- University Medical Center New Orleans, New Orleans
- Touro Infirmary, New Orleans
- og 1 flere
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- University Medical Center New Orleans, New Orleans
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Louisiana State University Health Sciences Center, New Orleans
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Louisiana State University Health Science Center, New Orleans
- University Medical Center New Orleans, New Orleans
- Ochsner Medical Center Jefferson, New Orleans
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, New Orleans
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RekruttererObservasjonsstudie
- Louisiana State University, New Orleans
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i New Orleans
- Kreft (alle typer)12 studier
- Eggstokkreft12 studier
- Prostatakreft10 studier
- Endometriekreft9 studier
- Metastatisk kreft9 studier
- Lungekreft9 studier
- Ikke-småcellet lungekreft9 studier
- Kardiovaskulær sykdom9 studier
- Fedme8 studier
- Steatotisk leversykdom8 studier
- Kolorektal kreft8 studier
- Atrieflimmer8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.